Case Report: Response to Immunotherapy and Anti-Androgen Therapy in Male Occult Triple-Negative Breast Cancer.

Wang, Xin-Hua; Zhang, Jing; Wu, Jie; He, Xiao-Han; Shen, Yan-Ru; Peng, Yong-Gang; An, Yu-Zhi.

Afiliação

Wang XH; Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Zhang J; Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Wu J; Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
He XH; Department of Medical Science, Berry Oncology Corporation, Beijing, China.
Shen YR; Department of Medical Science, Berry Oncology Corporation, Beijing, China.
Peng YG; Department of Medical Science, Berry Oncology Corporation, Beijing, China.
An YZ; Department of Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

Front Oncol ; 12: 840453, 2022.

Article em En | MEDLINE | ID: mdl-35433492